12-6620644-A-T

Variant summary

Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PM2PP3_Moderate

The ENST00000329858.9(LPAR5):​c.605T>A​(p.Leu202Gln) variant causes a missense change. The variant allele was found at a frequency of 0.000000713 in 1,402,662 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 33)
Exomes 𝑓: 7.1e-7 ( 0 hom. )

Consequence

LPAR5
ENST00000329858.9 missense

Scores

5
11
3

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 5.91
Variant links:
Genes affected
LPAR5 (HGNC:13307): (lysophosphatidic acid receptor 5) This gene encodes a member of the rhodopsin class of G protein-coupled transmembrane receptors. This protein transmits extracellular signals from lysophosphatidic acid to cells through heterotrimeric G proteins and mediates numerous cellular processes. Many G protein receptors serve as targets for pharmaceutical drugs. Transcript variants of this gene have been described.[provided by RefSeq, Dec 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 4 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.875

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
LPAR5NM_020400.6 linkuse as main transcriptc.605T>A p.Leu202Gln missense_variant 2/2 ENST00000329858.9 NP_065133.1 Q9H1C0Q5KU18
LPAR5NM_001142961.1 linkuse as main transcriptc.605T>A p.Leu202Gln missense_variant 2/2 NP_001136433.1 Q9H1C0Q5KU18
LOC105369631XR_007063192.1 linkuse as main transcriptn.658+2855A>T intron_variant

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
LPAR5ENST00000329858.9 linkuse as main transcriptc.605T>A p.Leu202Gln missense_variant 2/21 NM_020400.6 ENSP00000327875.4 Q9H1C0
LPAR5ENST00000431922.1 linkuse as main transcriptc.605T>A p.Leu202Gln missense_variant 2/22 ENSP00000393098.1 Q9H1C0
LPAR5ENST00000540335.1 linkuse as main transcriptn.962T>A non_coding_transcript_exon_variant 3/35

Frequencies

GnomAD3 genomes
Cov.:
33
GnomAD4 exome
AF:
7.13e-7
AC:
1
AN:
1402662
Hom.:
0
Cov.:
31
AF XY:
0.00
AC XY:
0
AN XY:
692616
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
9.24e-7
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
Cov.:
33

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsMay 13, 2024The c.605T>A (p.L202Q) alteration is located in exon 2 (coding exon 1) of the LPAR5 gene. This alteration results from a T to A substitution at nucleotide position 605, causing the leucine (L) at amino acid position 202 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.76
BayesDel_addAF
Uncertain
0.13
D
BayesDel_noAF
Uncertain
-0.050
CADD
Pathogenic
28
DANN
Uncertain
0.99
DEOGEN2
Benign
0.39
T;T
Eigen
Pathogenic
0.71
Eigen_PC
Uncertain
0.61
FATHMM_MKL
Uncertain
0.90
D
LIST_S2
Benign
0.79
T;.
M_CAP
Uncertain
0.19
D
MetaRNN
Pathogenic
0.88
D;D
MetaSVM
Uncertain
-0.047
T
MutationAssessor
Pathogenic
3.4
M;M
MutationTaster
Benign
1.0
D;D
PrimateAI
Uncertain
0.74
T
PROVEAN
Uncertain
-4.3
D;D
REVEL
Uncertain
0.44
Sift
Uncertain
0.0020
D;D
Sift4G
Pathogenic
0.0
D;D
Polyphen
1.0
D;D
Vest4
0.73
MutPred
0.69
Gain of catalytic residue at L202 (P = 0.0366);Gain of catalytic residue at L202 (P = 0.0366);
MVP
0.67
MPC
1.5
ClinPred
0.99
D
GERP RS
5.1
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.75
gMVP
0.48

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

No publications associated with this variant yet.

Other links and lift over

hg19: chr12-6729810; API